Total planned funding: $156,222,624
Allocations
Countries/Regions
Ukraine | $156,222,624 |
Organizational Types
Unknown | $48,498,253 |
NGO | $32,324,311 |
Private Contractor | $28,940,981 |
Own Agency | $21,209,338 |
Multi-lateral Agency | $10,125,607 |
University | $6,660,000 |
Implementing Agency | $3,925,040 |
Other USG Agency | $2,939,094 |
Host Country Government Agency | $1,600,000 |
Program Areas
Governance and Systems | $70,122,396 |
Treatment | $27,123,228 |
Testing | $17,576,416 |
Management and Operations | $15,470,667 |
Prevention | $15,389,678 |
Care | $10,540,239 |
Budget Codes
OHSS: Health Systems Strengthening | $41,470,437 |
HVSI: Strategic Information | $18,442,424 |
HVCT: Testing: HIV Testing and Counseling | $17,576,416 |
HVMS: Management and Operations | $15,470,667 |
HTXS: Treatment: Adult Treatment | $14,717,938 |
HTXD: Treatment: ARV Drugs | $12,405,290 |
HLAB: Laboratory Infrastructure | $10,209,535 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $7,800,954 |
HVTB: Care: TB/HIV | $5,761,014 |
HVOP: Sexual Prevention: Other Sexual Prevention | $5,282,402 |
HKID: Care: Orphans and Vulnerable Children | $2,484,131 |
HBHC: Care: Adult Care and Support | $2,295,094 |
HMBL: Biomedical Prevention: Blood Safety | $1,824,865 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $293,357 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $188,100 |
HMIN: Biomedical Prevention: Injection Safety | $0 |
Top Partner Programs
Not Available:
$44,728,253
Countries/Regions
Chemonics International:
$16,719,470
Countries/Regions
USG Aggregated Agencies:
$16,412,602
Countries/Regions
Deloitte Consulting Limited:
$10,671,511
Countries/Regions